Form 4: Cassava Sciences Director Richard Barry Reports Stock Option Grant

Director Richard Barry reports receiving a stock option grant for 15,000 shares of Cassava Sciences (SAVA) on May 9, 2024.

Summary

• Richard Barry, a director of Cassava Sciences Inc. (SAVA), reported a transaction on May 9, 2024.
• He received a stock option grant for 15,000 shares at an exercise price of $21.11.
• The options vest over one year at a rate of 1/12 per month and expire on May 9, 2034.
• The grant was made pursuant to the Non-employee Director Compensation Program approved by stockholders on May 4, 2023.
• Following the transaction, Barry directly owns 15,000 derivative securities.

Sentiment

Score: 6

Explanation: The document is a routine disclosure of a stock option grant, which is generally neutral. It indicates ongoing director compensation practices.

Positives

• The stock option grant aligns the director's interests with those of the shareholders.
• The vesting schedule encourages long-term commitment from the director.

Industry Context

Stock option grants are a common form of compensation for directors of publicly traded companies, aligning their interests with those of shareholders.

Stakeholder Impact

• The stock option grant could incentivize the director to work towards increasing shareholder value.

Key Dates